Malignancy. Not to be applied to potentially malignant or pre-malignant skin lesions; areas affected by acute cutaneous viral infections. Dermatological bacterial or fungal infections. Not recommended in patients w/ Netherton's syndrome or severely inflamed or damaged skin eg, erythroderma; immunocompromised patients. Monitor patients who develop lymphadenopathy. Discontinue in the presence of acute infectious mononucleosis. Minimize or avoid natural or artificial sunlight exposure. May cause mild & transient reactions at the site application. Avoid contact w/ eyes & mucous membranes. Pregnancy & lactation. Application to vaccination sites are not recommended.